Clin2
NCT07302035Possibly a fitNot yet recruiting

Safety of a single vaginal dose in healthy women

Bacterial Vaginosis

Part of Infections, Women’s health & pregnancy clinical trials.

This study tests a new medicine, given as a single vaginal dose, in healthy women. It is one of the first studies in humans, so the main goal is to see if the medicine is safe and how the body handles it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are a healthy woman aged 18 to 55.
  • You are sexually active and willing to use the study product as a vaginal insert.
  • You agree not to use other vaginal products (like lubricants, tampons, or spermicides) during the trial.
  • You have no significant health problems or abnormal lab results at the screening visit.
  • You have not had recent vaginal irritation, serious infections, or certain surgeries in the past few months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07663838Recruiting· Phase 1
Vaginal treatment for bacterial vaginosis

This study tests a new vaginal treatment for bacterial vaginosis (BV), a common infection causing itching, odor, and discharge. It aims to see if the treatment is safe and works well.

Beijing, Beijing Municipality
NCT07703241Not yet recruiting
Vaginal ovule for bacterial vaginosis or yeast infection

This study tests a vaginal ovule (a small tablet inserted into the vagina) to see if it safely treats two common vaginal infections: bacterial vaginosis and yeast infections (candidiasis). It may help relieve symptoms like discharge, itching, and burning.

Naples
NCT07875673Not yet recruiting· Phase 1
New study for treating bacterial vaginosis

This study tests two new investigational drugs to treat bacterial vaginosis. It aims to see if these drugs are safe and work well. If you have BV, this trial could give you access to a new treatment option.

Sydney, New South Wales
NCT07483671Not yet recruiting· Phase 2
Vaginal capsule plus antibiotic for bacterial vaginosis

This trial tests a new vaginal capsule called BPR-101, given together with the antibiotic metronidazole, to treat bacterial vaginosis (BV). If you have BV, this study aims to see if the combination is safe and effective in clearing the infection.

Tianjin
NCT07527572Not yet recruiting· Phase 2/Phase 3
Trial of a probiotic to prevent repeat bacterial vaginosis

This study tests whether a vaginal probiotic called Gyntima Balance can help prevent bacterial vaginosis from coming back. If you have had repeat infections, this might be a way to reduce future episodes.

NCT07234786Recruiting
Vaginal gel for treating and preventing vaginal infections

This trial tests a vaginal gel to treat and prevent common vaginal infections like yeast infections (VVC) and bacterial vaginosis (BV). It may help if you currently have symptoms like itching, discharge, or odor.

Quatre Bornes

Hear when a new Bacterial Vaginosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.